Skip to main content

Taking a GLP-1 Medication? Here's Tips to Holiday Eating

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 24, 2024.

By Robin Foster HealthDay Reporter

SATURDAY, Nov. 23, 2024 -- So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays near you worry about how to handle gatherings where decadent food will be served in abundance.

Luckily, one expert from Baylor College of Medicine has tips on how to enjoy holiday fare while on these medications, without overdoing it.

GLP-1 medications, which include Ozempic, Wegovy, Mounjaro and Zepbound, curb appetite and slow the digestion of food, so consuming large portions on these drugs can make you sick and worsens the nausea that is associated with them. What to do? Stick with small portions.

“You lose the benefit of weight loss if you do not watch your diet,” said Dr. Mandeep Bajaj, a professor of medicine – endocrinology, diabetes and metabolism at Baylor. “In addition, if you are taking GLP-1 receptor agonists for treatment of diabetes, overindulging will worsen your diabetes control, and you will lose the benefit of the therapy.”

Those who take GLP-1s should not stop taking them during the holidays, to avoid regaining the weight already lost. Tips to stay on track with your medication this holiday season include:

For those considering starting a GLP-1 medication, Bajaj does not recommend waiting.

“The whole purpose of treatment is diabetes control and weight loss in patients who are obese or overweight." he said in a Baylor news release. "There is no reason to delay it until the holidays are over, because that is the time when diabetes control worsens and you gain weight."

“Patients who take these medications realize that if they follow a healthy diet of more protein and fiber, they are able to lose weight. Combining these GLP-1 receptor agonist therapies with exercise is really important to get the benefits of the treatment,” Bajaj noted.

SOURCE: Baylor College of Medicine, news release, Nov. 19, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Weight-Loss Drugs May Lower Risk Of Obesity-Related Cancers

WEDNESDAY, May 28, 2025 — Popular GLP-1 weight loss drugs like Ozempic and Zepbound can help reduce a woman’s risk for as many as 14 cancers associated with obesity, a...

FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs

FRIDAY, May 23, 2025 — A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count...

Sugar, Fat and Salt on the Rise in U.S. Breakfast Cereals, Study Shows

THURSDAY, May 22, 2025 — They’re a go-to breakfast for millions of kids and adults. They’re brightly colored, packed in enticing boxes and often marketed as...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.